EPCAM and cancer: Although the prepared PLGA NPs with a nanoscale size distribution accumulated at the solid tumor site in a passive targeting manner by an “enhanced permeation and retention” effect [22], cell-specific targeting ability by EpCAM antibody conjugation is responsible for promoting their intracellular uptake within EpCAM-expressing cancer cells.